MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$11,935,000
EPS
-$0.24
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Royalties and license fees
-
-
-
0
Total revenues
0
0
0
-
Research and development
6,298,000
5,834,000
3,370,000
3,695,000
General and administrative
7,284,000
7,543,000
6,433,000
13,481,000
Total operating expenses
13,582,000
13,377,000
9,803,000
17,176,000
Loss from operations
-13,582,000
-13,377,000
-9,803,000
-17,176,000
Foreign currency transaction loss (gain)
70,000
131,000
-89,000
119,000
Interest income, net
1,594,000
1,390,000
1,011,000
1,036,000
Other expense, net
-17,000
19,000
-84,000
-123,500*
Loss on extinguishment of liabilities
0
0
-
-2,500*
Unrealized loss on investment
-
-
-
0*
Total other income, net
1,647,000
1,540,000
838,000
1,029,000
Net loss
-11,935,000
-11,837,000
-8,965,000
-16,147,000
Unrealized foreign currency translation gain (loss)
-
-
89,000
-
Total other comprehensive income (loss)
-
-
89,000
-
Total comprehensive loss
-
-
-8,876,000
-
Net loss attributable to common shareholders
-11,935,000
-11,837,000
-
-
Basic EPS
-0.24
-0.26
-0.22
-0.446
Diluted EPS
-0.24
-0.26
-0.22
-0.446
Basic Average Shares
49,386,203
45,970,516
41,521,280
36,209,271*
Diluted Average Shares
49,386,203
45,970,516
41,521,280
36,209,271*
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to common...
-$11,935,000
Interest income, net
$1,594,000
(93.68%↑ Y/Y)
Foreign currency
transaction loss (gain)
$70,000
(536.36%↑ Y/Y)
Net loss
-$11,935,000
(-27.59%↓ Y/Y)
Total other income,
net
$1,647,000
(97.48%↑ Y/Y)
Other expense, net
-$17,000
Loss from operations
-$13,582,000
(-33.31%↓ Y/Y)
Total operating
expenses
$13,582,000
(33.31%↑ Y/Y)
General and
administrative
$7,284,000
(73.10%↑ Y/Y)
Research and development
$6,298,000
(5.32%↑ Y/Y)
Buy us a coffee
Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. (BNTC)